Diabetes | Financial Buzz

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

Senseonics Reports PROMISE Study Results: 180 Day CGM Sensor

David Kim06/04/2021

2474

Senseonics Holdings, Inc. (NYSE: SENS) announced the results of its PROMISE Study that evaluates the accuracy and safety of the Eversense CGM System for up to 180 days with...

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

FDA Advisory Votes on Benefits of the Teplizumab to Outweigh Risks in Support of Approval to Delay Clinical Type 1 Diabetes

Andy Liao05/28/2021

2988

Provention Bio, Inc. (NASDAQ: PRVB) reported that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration voted 10 yes and 7 no on the...

Biotechnology Breaking News Buzz On The Street Healthcare Investing News Market News Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: Nemaura Medical (NASDAQ: NMRD) Application to List on Medical Catalog

financial buzz05/06/2021

2489

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Nemaura Medical Announces Progress on Listing of sugarBEAT® For Reimbursement in Germany.” Nemaura Medical, Inc. (NASDAQ:...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Market Buzz

Breaking News: Nemaura Medical Announces Progress on Listing of sugarBEAT® For Reimbursement in Germany

financial buzz05/06/2021

5836

Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today...

Biotechnology Breaking News Buzz On The Street Healthcare Investing News Market News Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: Nemaura Medical (NASDAQ: NMRD) Order for 200,000 sugarBEAT Sensors

financial buzz05/05/202105/06/2021

8495

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Nemaura Medical Announces Order for 200,000 sugarBEAT® Sensors.” Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”),...

Breaking News Healthcare Investing News Market News Technology The Market Buzz

Breaking News: Nemaura Medical Announces Order for 200,000 sugarBEAT® Sensors

financial buzz05/05/2021

5570